Oxcarbazepine.
Jensen
P K
PK
R&D Department, CIBA-GEIGY Ltd., Basle, Switzerland.
Gram
L
L
Schmutz
M
M
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004569:Electroencephalography / Q000187:drug effects; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D005071:Evoked Potentials / Q000187:drug effects; D006801:Humans; D000078330:Oxcarbazepine; D013329:Structure-Activity Relationship
D000927:Anticonvulsants; D015507:Drugs, Investigational; D002220:Carbamazepine; D000078330:Oxcarbazepine